Prostate cancer is one of the most common cancers affecting men in Slovenia and worldwide. Prostate cancer diagnosis is based on histopathological biopsy findings. After the diagnosis has been made, magnetic resonance imaging plays an important role in determining the stage of the disease and in planning individualised treatment. The initial imaging assessment of prostate cancer is acquired from T1- and T2-weighted magnetic resonance imaging sequences in different planes. High resolution T2-weighted magnetic resonance imaging with excellent soft tissue differentiation provides the best depiction of the prostate gland and adjacent anatomical structures. In magnetic resonance imaging protocols, these morphologic sequences are joined by modern or physiology-based magnetic resonance techniques. Among the clinically most useful and accessible functional magnetic resonance sequences are diffusion-weighted magnetic resonance imaging, dynamic contrast-enhanced magnetic resonance imaging, and magnetic resonance spectroscopy, all of which significantly contribute to a higher quality in assessing tumour staging, volume, aggressiveness and recurrence. This article presents magnetic resonance imaging sequences in prostate cancer patient care.